278 related articles for article (PubMed ID: 24030132)
1. Team-based approach to addressing simvastatin safety concerns.
Robinson M; Gunning K; Pippitt K; McAdam-Marx C; Jennings BT
J Am Pharm Assoc (2003); 2013; 53(5):539-44. PubMed ID: 24030132
[TBL] [Abstract][Full Text] [Related]
2. Impact of pharmacists' interventions and simvastatin dose restrictions.
Shoulders BR; Franks AS; Barlow PB; Williams JD; Farland MZ
Ann Pharmacother; 2014 Jan; 48(1):54-61. PubMed ID: 24259645
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
4. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
[TBL] [Abstract][Full Text] [Related]
5. Establishing a clinical pharmacy technician at a United States Army military treatment facility.
Evans JL; Gladd EM; Gonzalez AC; Tranam S; Larrabee JM; Lipphardt SE; Chen TT; Ronn MD; Spain J
J Am Pharm Assoc (2003); 2016; 56(5):573-579.e1. PubMed ID: 27498312
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
[TBL] [Abstract][Full Text] [Related]
8. Impact of an automated dispensing system in outpatient pharmacies.
Humphries TL; Delate T; Helling DK; Richardson B
J Am Pharm Assoc (2003); 2008; 48(6):774-9. PubMed ID: 19019807
[TBL] [Abstract][Full Text] [Related]
9. Integration of pharmacists into a patient-centered medical home.
Scott MA; Hitch B; Ray L; Colvin G
J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
[TBL] [Abstract][Full Text] [Related]
10. Integration and compensation of pharmacists into primary care medical groups.
Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
[TBL] [Abstract][Full Text] [Related]
11. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
Prom R; Umscheid CA; Kasbekar N; Spinler SA
Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
[No Abstract] [Full Text] [Related]
12. Pharmacist integration into the medical home: qualitative analysis.
Kozminski M; Busby R; McGivney MS; Klatt PM; Hackett SR; Merenstein JH
J Am Pharm Assoc (2003); 2011; 51(2):173-83. PubMed ID: 21382807
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pharmacy resident and student recommendations made before and after home-based primary care patient visits.
Poon LH; Wang L; Moody S; Proffitt L
Consult Pharm; 2015 Jan; 30(1):45-9. PubMed ID: 25591031
[TBL] [Abstract][Full Text] [Related]
14. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
15. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
16. Organizational factors influencing pharmacy practice change.
Doucette WR; Nevins JC; Gaither C; Kreling DH; Mott DA; Pedersen CA; Schommer JC
Res Social Adm Pharm; 2012; 8(4):274-84. PubMed ID: 21958467
[TBL] [Abstract][Full Text] [Related]
17. An off-site clinical pharmacy service in family medicine: development and 1-year outcomes.
Vande Griend JP; Saseen JJ; Bislip D; Moore G; Conry C
Fam Med; 2014 May; 46(5):348-53. PubMed ID: 24915477
[TBL] [Abstract][Full Text] [Related]
18. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
Dhanani TC; Mantovani EH; Turner JR
Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
